Does maintaining SBP at 120-129 mmHg and DBP at 75-79 mmHg reduce the incidence of MACE and mortality in patients with T2DM?
In patients with T2DM, maintaining SBP between 120-129 mmHg and DBP between 75-79 mmHg is associated with the lowest risk of MACE and mortality, with even lower SBP targets potentially benefiting those at high renal risk.
In patients with T2DM, the optimal cutoff value of BP associated with a lower incidence of MACE and mortality may be 120-129 mmHg for SBP and 75-79 mmHg for DBP. However, lower SBP may be helpful for T2DM patients with a high risk of renal disease.
Kim et al. (Tue,) studied this question.